{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:16:50Z","timestamp":1779398210509,"version":"3.53.1"},"reference-count":22,"publisher":"Associa\u00e7\u00e3o de Medicina Intensiva Brasileira","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"DOI":"10.62675\/2965-2774.20260352","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:55:17Z","timestamp":1779396917000},"source":"Crossref","is-referenced-by-count":0,"title":["Monotherapy versus combination therapy for treatment of carbapenem-resistant Acinetobacter baumannii complex infections: results from an observational study"],"prefix":"10.62675","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7564-2750","authenticated-orcid":false,"suffix":"Filho","given":"Sidnei Umberto","family":"Bertholdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4078-2046","authenticated-orcid":false,"given":"Jo\u00e3o Paulo","family":"Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0592-3715","authenticated-orcid":false,"given":"Igor Mochiutti de","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4577-9077","authenticated-orcid":false,"given":"Daniela Kall\u00edope de S\u00e1","family":"Paraskevopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0065-3963","authenticated-orcid":false,"given":"Carolina Hikari","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3085-9073","authenticated-orcid":false,"given":"Allan Homero dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3471-1786","authenticated-orcid":false,"given":"Felipe Francisco","family":"Tuon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Silva de","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1269-9958","authenticated-orcid":false,"given":"Augusto","family":"Yamaguti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7282-5453","authenticated-orcid":false,"given":"Tha\u00eds","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"49293","reference":[{"key":"key20260521205512_B1","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections","author":"Tamma","year":"2024","unstructured":"1. Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin Infect Dis. 2024:ciae403.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"key20260521205512_B2","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-4811-8","article-title":"Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study","volume":"20","author":"Motbainor","year":"2020","unstructured":"2. Motbainor H, Bereded F, Mulu W. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis. 2020;20(1):92.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"key20260521205512_B3","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1695-8","article-title":"Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis","volume":"16","author":"Le\u00e3o","year":"2016","unstructured":"3. Le\u00e3o AC, Menezes PR, Oliveira MS, Levin AS. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis. BMC Infect Dis. 2016;16(1):386.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"key20260521205512_B4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","article-title":"Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review","volume":"41","author":"Yaghoubi","year":"2022","unstructured":"4. Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M, et al. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. 2022;41(7):1003-22.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"key20260521205512_B5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/phar.2802","article-title":"Sulbactam-durlobactam: A novel \u00df-lactam-\u00df-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections","volume":"43","author":"El-Ghali","year":"2023","unstructured":"5. El-Ghali A, Kunz Coyne AJ, Caniff K, Bleick C, Rybak MJ. Sulbactam-durlobactam: A novel \u00df-lactam-\u00df-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections. Pharmacotherapy. 2023;43(6):502-13.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"key20260521205512_B6","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter baumannii antibiotic resistance mechanisms","volume":"10","author":"Kyriakidis","year":"2021","unstructured":"6. Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens. 2021;10(3):373.","journal-title":"Pathogens"},{"issue":"1","key":"key20260521205512_B7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges","volume":"30","author":"Wong","year":"2017","unstructured":"7. Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30(1):409-47.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"key20260521205512_B8","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.04808-14","article-title":"Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii","volume":"59","author":"Penwell","year":"2015","unstructured":"8. Penwell WF, Shapiro AB, Giacobbe RA, Gu RF, Gao N, Thresher J, et al. Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii. Antimicrob Agents Chemother. 2015;59(3):1680-9.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"key20260521205512_B9","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200131","article-title":"Colistin monotherapy versus combination therapy for carbapenem-resistant organisms","volume":"2","author":"Kaye","year":"2023","unstructured":"9. Kaye KS, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu CH, Daikos G, et al. Colistin monotherapy versus combination therapy for carbapenem-resistant organisms. NEJM Evid. 2023;2(1):evidoa2200131.","journal-title":"NEJM Evid"},{"key":"key20260521205512_B10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.709974","article-title":"Durlobactam, a new diazabicyclooctane \u00df-lactamase inhibitor for the treatment of Acinetobacter infections in combination with sulbactam","volume":"12","author":"Shapiro","year":"2021","unstructured":"10. Shapiro AB, Moussa SH, McLeod SM, Durand-R\u00e9ville T, Miller AA. Durlobactam, a new diazabicyclooctane \u00df-lactamase inhibitor for the treatment of Acinetobacter infections in combination with sulbactam. Front Microbiol. 2021;12:709974.","journal-title":"Front Microbiol"},{"issue":"9","key":"key20260521205512_B11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1473-3099(23)00184-6","article-title":"Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)","volume":"23","author":"Kaye","year":"2023","unstructured":"11. Kaye KS, Shorr AF, Wunderink RG, Du B, Poirier GE, Rana K, et al. Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK). Lancet Infect Dis. 2023;23(9):1072-84.","journal-title":"Lancet Infect Dis"},{"key":"key20260521205512_B12","author":"Brazilian Committee on Antimicrobial Susceptibility Testing (BrCAST)","unstructured":"12. Brazilian Committee on Antimicrobial Susceptibility Testing (BrCAST). Documentos\/Subcomit\u00ea Antif\u00fangicos\/Documentos (Subcomit\u00ea Antif\u00fangico). Tabelas de ponto de corte. Dispon\u00edvel em: https:\/\/brcast.org.br\/documentos\/documentos\/","journal-title":"Documentos\/Subcomit\u00ea Antif\u00fangicos\/Documentos (Subcomit\u00ea Antif\u00fangico). Tabelas de ponto de corte"},{"issue":"5","key":"key20260521205512_B13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","unstructured":"13. Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32.","journal-title":"Am J Infect Control"},{"issue":"3","key":"key20260521205512_B14","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S2666-5247(22)00355-X","article-title":"Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Langford","year":"2023","unstructured":"14. Langford BJ, So M, Simeonova M, Leung V, Lo J, Kan T, et al. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. Lancet Microbe. 2023;4(3):e179-91.","journal-title":"Lancet Microbe"},{"issue":"1","key":"key20260521205512_B15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajic.2021.09.018","article-title":"Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil","volume":"50","author":"Polly","year":"2022","unstructured":"15. Polly M, de Almeida BL, Lennon RP, Cort\u00eas MF, Costa SF, Guimar\u00e3es T. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil. Am J Infect Control. 2022;50(1):32-8.","journal-title":"Am J Infect Control"},{"issue":"3","key":"key20260521205512_B16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jiph.2022.12.022","article-title":"Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review","volume":"16","author":"Abubakar","year":"2023","unstructured":"16. Abubakar U, Al-Anazi M, Alanazi Z, Rodr\u00edguez-Ba\u00f1o J. Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review. J Infect Public Health. 2023;16(3):320-31.","journal-title":"J Infect Public Health"},{"key":"key20260521205512_B17","author":"S\u00e3o Paulo","year":"2023","unstructured":"17. S\u00e3o Paulo. Governo do Estado. Centro de Vigil\u00e2ncia Epidemiol\u00f3gica \"Prof. Alexandre Vranjac\". Coordenadoria de Controle de Doen\u00e7as. Sistema de Vigil\u00e2ncia Epidemiol\u00f3gica IRAS Estado de S\u00e3o Paulo, 2023. [citado 2024 Nov 20]. Dispon\u00edvel em: https:\/\/portal.saude.sp.gov.br\/resources\/cve-centro-de-vigilancia-epidemiologica\/areas-de-vigilancia\/infeccao-hospitalar\/dados\/apresentacao_dados_iras_2023.pdf","journal-title":"Sistema de Vigil\u00e2ncia Epidemiol\u00f3gica IRAS Estado de S\u00e3o Paulo"},{"issue":"1","key":"key20260521205512_B18","article-title":"Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection","volume":"5","author":"Chen","year":"2015","unstructured":"18. Chen Z, Chen Y, Fang Y, Wang X, Chen Y, Qi Q, et al. Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection. Sci Rep. 2015;5(1):17091.","journal-title":"Sci Rep"},{"issue":"5","key":"key20260521205512_B19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107120","article-title":"International guidelines for the treatment of carbapenem-resistant Gram-negative Bacilli infections: a comparison and evaluation","volume":"63","author":"Wang","year":"2024","unstructured":"19. Wang C, Bai C, Chen K, Du Q, Cheng S, Zeng X, et al. International guidelines for the treatment of carbapenem-resistant Gram-negative Bacilli infections: a comparison and evaluation. Int J Antimicrob Agents. 2024;63(5):107120.","journal-title":"Int J Antimicrob Agents"},{"key":"key20260521205512_B20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","article-title":"Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"24","author":"Liu","year":"2021","unstructured":"20. Liu J, Shu Y, Zhu F, Feng B, Zhang Z, Liu L, et al. Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis. J Glob Antimicrob Resist. 2021;24:136-47.","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"key20260521205512_B21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial","volume":"18","author":"Paul","year":"2018","unstructured":"21. Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, et al. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet Infect Dis. 2018;18(4):391-400.","journal-title":"Lancet Infect Dis"},{"key":"key20260521205512_B22","author":"Brasil","year":"2018","unstructured":"22. Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. Plano de a\u00e7\u00e3o nacional de preven\u00e7\u00e3o e controle da resist\u00eancia aos antimicrobianos no \u00e2mbito da sa\u00fade \u00fanica: 2018-2022. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2018.","journal-title":"Plano de a\u00e7\u00e3o nacional de preven\u00e7\u00e3o e controle da resist\u00eancia aos antimicrobianos no \u00e2mbito da sa\u00fade \u00fanica: 2018-2022"}],"container-title":["Critical Care Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:55:22Z","timestamp":1779396922000},"score":1,"resource":{"primary":{"URL":"https:\/\/criticalcarescience.org\/article\/monotherapy-versus-combination-therapy-for-treatment-of-carbapenem-resistant-acinetobacter-baumannii-complex-infections-results-from-an-observational-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"alternative-id":["10.62675\/2965-2774.20260352"],"URL":"https:\/\/doi.org\/10.62675\/2965-2774.20260352","relation":{},"ISSN":["2965-2774"],"issn-type":[{"value":"2965-2774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20260352"}}